drugset / Trial / NCT02314754
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48 hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77 days' compared to women 64-70 days' LMP.
Timeline
- Start
- 2014-12
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | Oral |
| Subject | Misoprostol | Other / unclassified | 800 ug | Other |
Indications
No indication recorded.